Kerala CM Pinarayi Vijayan   |  Photo Credit: ANI
- ‘COVID-19 vaccinewill be made available free of cost to all people in Kerala’
- ‘No one will be charged for the vaccine. This is the stand of the government’
- Five vaccine candidates are under different phases of clinical trials in India
New Delhi: COVID-19 vaccine will be provided free of cost in Kerala, announced Chief Minister Pinarayi Vijayan. However, the CM said the quantity of the vaccine that would be allotted to the state by the Centre was not yet known.
This makes Kerala the third state to announce the free rollout of coronavirus vaccine after Tamil Nadu and Madhya Pradesh.
In October, Tami Nadu Chief Minister Edappadi K. Palaniswami had announced that the vaccine will be provided to all people of the state free of cost once it is ready. Similarly, Madhya Pradesh also announced free vaccination at the end of October.
‘Quantity of vaccine that would be allotted to Kerala not known’
Taking to his Twitter, Chouhan said: “Coronavirus vaccine preparation work is going on fast in India. As soon as the vaccine is ready, it will be made available to every citizen of Madhya Pradesh for free.”
The announcement comes at a time when the state recorded 5,949 new COVID-19 cases and 32 deaths today, thereby taking the tally to 6.64 lakh and the toll to 2,59.
5,268 people getting cured taking the total recoveries to 6, 01,861 while the active cases stood at 60,029.
The total COVID-19 cases in the state touched 6, 64,632.
Tamil Nadu, MP already made similar announcement
Meanwhile, the CM has urged people to exercise extreme caution to prevent the spread of the disease otherwise the situation in the state would worsen further.
“The fact is that the number of COVID-19 cases are decreasing, which is a matter of relief. However, it needs to be seen if the local body polls, two phases of which are over, would contribute to increase in cases. That will be known only in the days to come,” PTI quoted Vijayan as saying.
On Tuesday, the Centre said that three coronavirus vaccines developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of drug regulator.